340B Drug Pricing Program
AHA Dec. 22 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
Grady Health System – comprised of Grady Memorial Hospital, a children’s hospital, and ten outpatient care centers – is a health care anchor for the Atlanta community. The 340B Drug Pricing Program is essential to preserving Grady’s ability to provide high-quality, patient-centered care to all, no…
To assist members in their efforts to obtain reimbursement under their contracts with their MAO plans, we have identified and spoken with four outside law firms that have considerable experience with 340B questions and litigating against insurers on issues like these.
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
Following years of litigation and a unanimous Supreme Court win, the AHA is very pleased that 340B hospitals finally will be reimbursed in full for what HHS unlawfully withheld from them for five years.
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
The Health Resources and Services Administration will require hospitals in the 340B Drug Pricing Program to register their off-site outpatient departments with the 340B Office of Pharmacy Affairs within 90 days.
Report: 340B tax-exempt hospitals provided more than $84 billion benefits to communities in 2020
In 2020, the most recent year for which this information is available, tax-exempt hospitals participating in the 340B drug savings program provided $84.4B in total benefits to their communities. Total community benefits for 340B hospitals increased from $67.9 billion in 2019 to $84.4 billion in…